HA
HHLR Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,582,635
| Closed | -$31.3M | – | 52 |
|
|
2024
Q4 | $31.3M | Hold |
1,582,635
| – | – | 1.08% | 15 |
|
|
2024
Q3 | $39.6M | Sell |
1,582,635
-1,561,921
| -50% | -$39M | 0.87% | 14 |
|
|
2024
Q2 | $58.7M | Buy |
3,144,556
+8,821
| +0.3% | +$165K | 1.45% | 10 |
|
|
2024
Q1 | $61.9M | Buy |
+3,135,735
| New | +$61.9M | 1.34% | 13 |
|
|
2023
Q4 | – | Sell |
-698,741
| Closed | -$12.1M | – | 56 |
|
|
2023
Q3 | $12.1M | Hold |
698,741
| – | – | 0.27% | 33 |
|
|
2023
Q2 | $9.84M | Sell |
698,741
-319,350
| -31% | -$4.5M | 0.21% | 36 |
|
|
2023
Q1 | $11M | Sell |
1,018,091
-1,605,833
| -61% | -$17.3M | 0.19% | 42 |
|
|
2022
Q4 | $39.3M | Sell |
2,623,924
-296,099
| -10% | -$4.44M | 0.83% | 21 |
|
|
2022
Q3 | $37.5M | Hold |
2,920,023
| – | – | 0.99% | 21 |
|
|
2022
Q2 | $28.3M | Hold |
2,920,023
| – | – | 0.61% | 25 |
|
|
2022
Q1 | $29M | Hold |
2,920,023
| – | – | 0.61% | 25 |
|
|
2021
Q4 | $34.4M | Hold |
2,920,023
| – | – | 0.53% | 29 |
|
|
2021
Q3 | $33.3M | Hold |
2,920,023
| – | – | 0.44% | 35 |
|
|
2021
Q2 | $40.7M | Hold |
2,920,023
| – | – | 0.42% | 38 |
|
|
2021
Q1 | $54.1M | Hold |
2,920,023
| – | – | 0.53% | 27 |
|
|
2020
Q4 | $51.6M | Hold |
2,920,023
| – | – | 0.41% | 34 |
|
|
2020
Q3 | $44.7M | Buy |
2,920,023
+476,190
| +19% | +$7.3M | 0.34% | 32 |
|
|
2020
Q2 | $62.3M | Buy |
2,443,833
+547,945
| +29% | +$14M | 0.57% | 29 |
|
|
2020
Q1 | $29.3M | Hold |
1,895,888
| – | – | 0.4% | 32 |
|
|
2019
Q4 | $21M | Buy |
1,895,888
+28,266
| +2% | +$313K | 0.26% | 35 |
|
|
2019
Q3 | $15.9M | Buy |
1,867,622
+31,734
| +2% | +$270K | 0.22% | 46 |
|
|
2019
Q2 | $24.9M | Hold |
1,835,888
| – | – | 0.56% | 27 |
|
|
2019
Q1 | $33.2M | Buy |
1,835,888
+447,000
| +32% | +$8.07M | 0.92% | 20 |
|
|
2018
Q4 | $39M | Buy |
+1,388,888
| New | +$39M | 1.62% | 13 |
|